Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target boosted by equities research analysts at BMO Capital Markets from $300.00 to $360.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price objective indicates a potential upside of 11.82% from […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target boosted by equities research analysts at BMO Capital Markets from $300.00 to $360.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price objective indicates a potential upside of 11.82% from […]
